Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C - Wikidata - awgldk - TriplyDB

Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C

Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C

http://www.wikidata.org/entity/Q36920164

about

Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma Is mother-to-infant transmission the most important factor for persistent HBV infection?A Convenient Truth: Cost of Medications Need Not Be a Barrier to Hepatitis B Treatment Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in Taiwan Hepatitis B virus and hepatitis C virus dual infection.Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the SEER database.Clinicopathological features and prognostic factors of young patients with surgically treated liver cancer Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?Phosphatase and tensin homologue genetic polymorphisms and their interactions with viral mutations on the risk of hepatocellular carcinoma.Hospital stays for hepatitis B or C virus infection or primary liver cancer among immigrants: a census-linked population-based cohort study.Clinical characteristics of patients with hepatocellular carcinoma in a middle eastern population Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.A research note regarding "Variation in cancer risk among tissues can be explained by the number of stem cell divisions".Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.Adjuvant therapy for early colon cancer: current status.Personalized treatment of colorectal cancer.Why do targeted agents not work in the adjuvant setting in colon cancer?Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma.Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma.Impact of etiological treatment on prognosis.Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease.The Exceptional Oncogenicity of HTLV-1 Causal Mediation Analysis of Survival Outcome with Multiple Mediators.Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).Detection of Hepatocyte Clones Containing Integrated Hepatitis B Virus DNA Using Inverse Nested PCR.Mediation effect of hepatitis B and C on mortality.Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.Robust Regression Analysis of GCMS Data Reveals Differential Rewiring of Metabolic Networks in Hepatitis B and C Patients.Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.Hepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics.

P2860

Q26778413-7518B201-F039-4D11-BA2E-E8A81F0F2E78 Q28083160-B5A81B5F-2918-4FAB-9515-6343FBC57EA6 Q28386440-07A77932-2343-442F-9AD5-322469EDE538 Q30391932-3CFFA5FD-CF2E-4E91-9E70-C322736BFA38 Q33559298-E2462C39-B7A8-4AB5-840F-0A2387ED872D Q33661172-9D5DA7A9-5BCC-4A58-949E-BFC7E0A36B85 Q33851416-511A8AEB-9A64-4DA6-AA19-3EF4BE337256 Q34194760-220F49EC-E13A-4A46-BE8A-1FE2665E4188 Q34233722-0C1B4430-6244-4D4B-8A82-3AE3ACE58058 Q34404975-ECF5A3CB-5A9A-4677-9138-FD7AE879ADA3 Q34629791-5178CB32-C332-443A-8B6B-B73D569A10F0 Q35176097-BC7F7003-A3E9-48A4-BA22-FD23121B7298 Q36009055-F132F875-922E-4B07-86ED-5115F0C79EB2 Q36102532-C1678F61-A9DF-49AD-9832-1591A6669BD8 Q36801410-F58E3956-EA4E-4973-9DD5-ECB79B91740E Q37066862-776E7A00-7A5E-4EDE-BA6C-2591CCE3446D Q37067779-95E05955-4E67-491D-827F-663A60BF9801 Q37207070-1E5AE58C-932F-465E-A619-A455957ACB36 Q37329859-A4445F10-FB77-4F40-B153-1EFC9987D1BA Q37384243-FF3EDB55-D756-4206-A6AC-E5AF859CDAB0 Q37654521-908C4615-0CE8-439A-957D-0F6D2EC20483 Q37956401-813342CC-5C20-4716-B2EC-2FB047A75616 Q37979676-B1AE20F2-B40C-4457-9CDB-30C358DE3CC7 Q38062021-81BDDD2B-2E4F-4A84-A8C7-F3C0EE138A0C Q38160511-5CFB814A-57F8-4E9D-86A4-FDC3B3303FA4 Q38339878-2DC6BADE-44AD-4279-9873-6B757D8CC869 Q38662540-D8994999-22A2-4EBA-9D99-B37FE3C139F9 Q38748915-A9801905-F36C-4980-B645-C86807A378EC Q39431994-7B76789B-53AF-4369-B7AA-879CFF7A9300 Q39494137-E53DF6A8-B7BD-45DC-9569-049A8A50B0B8 Q39504805-73A7177B-16FB-49B7-80FC-1C65E8E45C62 Q40291207-0BEE0488-1D96-490F-86CA-77FB0BCF4785 Q40328972-311814DA-FBBF-4D00-833F-B830C742A91F Q40409372-AE808D1E-AA2F-4469-A5AC-25819CE3D1B1 Q40823860-126DB405-8F4A-40B2-BDA5-7BA428FC022E Q41412095-989D464A-A17B-4851-B584-7D4B8B58CEF2 Q41921666-0F8954AF-CE30-4C47-8FC0-D6BEE26DFF96 Q42177592-2CA1C3D8-53BA-4307-971F-ECD1DC6FC5BB Q42223486-0A73E499-8A14-4578-9514-5C46AAB545A9 Q42228388-79D83BA8-12A4-4E5E-A52D-077B2E8E409A

P2860

Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C

http://www.wikidata.org/entity/Q36920164

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Lifetime risk and sex differen ...... with chronic hepatitis B and C

@en

type

label

Lifetime risk and sex differen ...... with chronic hepatitis B and C

@en

prefLabel

Lifetime risk and sex differen ...... with chronic hepatitis B and C

@en

P1433

Q36920164-8167AD0A-83BF-415E-9AA2-43B4E20245D1

P1476

Q36920164-C7E4FA11-F025-46A6-AC20-8A69B04B8894

P2093

Q36920164-30C8A0E8-5BE3-452A-B93C-848E8FC90489

Q36920164-3763F579-7E6A-4220-B358-65A05F269C2F

Q36920164-506D651A-4E23-4F79-85D7-2565260C32A0

Q36920164-59B4A72D-39A4-447B-82F8-8840ACF2F4D6

Q36920164-6F7608A3-5059-4F65-B506-C70A36F37E7C

Q36920164-84B8F974-5369-4F68-83D3-0540809B2483

Q36920164-856023B0-C751-4F25-A6CE-DC16B82EE1A9

Q36920164-C12C7A4D-61AA-4710-826A-9F28A3EFD3C9

P2860

Q36920164-00EBC1C0-A472-45A3-A972-60B0FF8E2DE6

Q36920164-07F3E916-60B6-444A-8319-94370A422530

Q36920164-1D044CAF-2967-437A-B018-E79894346288

Q36920164-1FE2B25E-69C4-4663-8C4B-7D0C7F9B402A

Q36920164-21EFA410-4D47-4F2D-8E12-CED319D23CF2

Q36920164-3017F538-B997-4F1E-ADA6-B5F957A6F36F

Q36920164-393C1BBC-89B1-406F-8900-738D9804F5C8

Q36920164-3ADC2C1B-B85B-4063-8284-F8D4DF65573A

Q36920164-3DBA17C6-72CB-485C-89FC-56ACEBC554B6

Q36920164-4F37CFD5-8812-4F0F-A200-00263E3366FB

P304

Q36920164-FF52EDB2-8AF6-40F4-AB92-6116E6CC0C01

P31

Q36920164-544022A8-9065-44F5-A0D5-D59415D80723

P356

Q36920164-E6CD048D-1B59-49E3-9F70-4B43E9A465F7

P407

Q36920164-0F0759E5-73AC-4B90-849D-B1EC8A4EBE73

P433

Q36920164-B26B7332-A30A-4833-915F-B003B6F5F999

P478

Q36920164-6F64EEFC-849C-49C3-82F0-3677784BF25E

P577

Q36920164-DCA0690D-7291-4DBB-8A60-5B852A654208

P5875

Q36920164-05268245-79CD-45D7-B07E-2A69D75298B1

P698

Q36920164-8828DF5F-E5D0-48D6-91F6-0174CFC5236C

P932

Q36920164-7906E6B2-8709-401C-956F-E4F233BACD4B

P356

JCO.2011.36.2335

P1433

Journal of Clinical Oncology

P1476

Lifetime risk and sex differen ...... with chronic hepatitis B and C

@en

P2093

Chien-Jen Chen

http://www.w3.org/2001/XMLSchema#string

Chin-Lan Jen

http://www.w3.org/2001/XMLSchema#string

Hwai-I Yang

http://www.w3.org/2001/XMLSchema#string

Jun Su

http://www.w3.org/2001/XMLSchema#string

Mei-Hsuan Lee

http://www.w3.org/2001/XMLSchema#string

Sheng-Nan Lu

http://www.w3.org/2001/XMLSchema#string

Uchenna H Iloeje

http://www.w3.org/2001/XMLSchema#string

Yen-Tsung Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells

Global cancer statistics, 2002

Hepatitis C virus infection

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan.

Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.

Seropositivity of hepatitis B e antigen and hepatocellular carcinoma.

Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis.

A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China.

Epidemiology of hepatitis B virus infection in the Asia-Pacific region.

P304

3643-3650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2011.36.2335

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51588746

http://www.w3.org/2001/XMLSchema#string

P698

21859997

http://www.w3.org/2001/XMLSchema#string

P932

4874144

http://www.w3.org/2001/XMLSchema#string